Concepedia

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

Guadalupe García–Tsao, Jaime Bosch, Zeid Kayali, Stephen A. Harrison, Manal F. Abdelmalek, Eric Lawitz, Sanjaya K. Satapathy, Marwan Ghabril, Mitchell L. Shiffman, Ziad Younes,

Journal of Hepatology · 2019 · 156 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Portal hypertensive bleeding in cirrhosis

Guadalupe García–Tsao, Juan G. Abraldeṣ, Annalisa Berzigotti et al. · Hepatology · 2016 · 2.1K citations

, , +17

Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis

Cristina Ripoll, Roberto J. Groszmann, Guadalupe García–Tsao et al. · Gastroenterology · 2007 · 1.2K citations · Full text

, , +10

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Càndid Villanueva, Agustı́n Albillos, Joan Genescà et al. · The Lancet · 2019 · 671 citations

, , +8

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

Mazen Noureddin, Aarshi Vipani, Catherine Bresee et al. · The American Journal of Gastroenterology · 2018 · 575 citations · Full text

, , +16

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 389 citations

, , +17